These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31373442)

  • 1. Circulating IGFBP-2: a novel biomarker for incident dementia.
    McGrath ER; Himali JJ; Levy D; Conner SC; DeCarli CS; Pase MP; Courchesne P; Satizabal CL; Vasan RS; Beiser AS; Seshadri S
    Ann Clin Transl Neurol; 2019 Sep; 6(9):1659-1670. PubMed ID: 31373442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study.
    McGrath ER; Himali JJ; Levy D; Conner SC; Pase MP; Abraham CR; Courchesne P; Satizabal CL; Vasan RS; Beiser AS; Seshadri S
    PLoS One; 2019; 14(3):e0213321. PubMed ID: 30830941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth Differentiation Factor 15 and NT-proBNP as Blood-Based Markers of Vascular Brain Injury and Dementia.
    McGrath ER; Himali JJ; Levy D; Conner SC; DeCarli C; Pase MP; Ninomiya T; Ohara T; Courchesne P; Satizabal CL; Vasan RS; Beiser AS; Seshadri S
    J Am Heart Assoc; 2020 Oct; 9(19):e014659. PubMed ID: 32921207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating ceramide ratios and risk of vascular brain aging and dementia.
    McGrath ER; Himali JJ; Xanthakis V; Duncan MS; Schaffer JE; Ory DS; Peterson LR; DeCarli C; Pase MP; Satizabal CL; Vasan RS; Beiser AS; Seshadri S
    Ann Clin Transl Neurol; 2020 Feb; 7(2):160-168. PubMed ID: 31950603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
    de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
    Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes.
    Pase MP; Beiser AS; Himali JJ; Satizabal CL; Aparicio HJ; DeCarli C; Chêne G; Dufouil C; Seshadri S
    JAMA Neurol; 2019 May; 76(5):598-606. PubMed ID: 30830207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma EFEMP1 Is Associated with Brain Aging and Dementia: The Framingham Heart Study.
    McGrath ER; Himali JJ; Levy D; Yang Q; DeCarli CS; Courchesne P; Satizabal CL; Finney R; Vasan RS; Beiser AS; Seshadri S
    J Alzheimers Dis; 2022; 85(4):1657-1666. PubMed ID: 34958018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of prevalent and incident dementia associated with insulin-like growth factor and insulin-like growth factor-binding protein 3.
    Almeida OP; Hankey GJ; Yeap BB; Paul Chubb SA; Gollege J; Flicker L
    Mol Psychiatry; 2018 Aug; 23(8):1825-1829. PubMed ID: 29155799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease.
    Johansson P; Åberg D; Johansson JO; Mattsson N; Hansson O; Ahrén B; Isgaard J; Åberg ND; Blennow K; Zetterberg H; Wallin A; Svensson J
    Psychoneuroendocrinology; 2013 Sep; 38(9):1729-37. PubMed ID: 23473966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma beta amyloid and the risk of Alzheimer disease and dementia in elderly men: a prospective, population-based cohort study.
    Sundelöf J; Giedraitis V; Irizarry MC; Sundström J; Ingelsson E; Rönnemaa E; Arnlöv J; Gunnarsson MD; Hyman BT; Basun H; Ingelsson M; Lannfelt L; Kilander L
    Arch Neurol; 2008 Feb; 65(2):256-63. PubMed ID: 18268197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of amine biomarkers with incident dementia and Alzheimer's disease in the Framingham Study.
    Chouraki V; Preis SR; Yang Q; Beiser A; Li S; Larson MG; Weinstein G; Wang TJ; Gerszten RE; Vasan RS; Seshadri S
    Alzheimers Dement; 2017 Dec; 13(12):1327-1336. PubMed ID: 28602601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study.
    van Himbergen TM; Beiser AS; Ai M; Seshadri S; Otokozawa S; Au R; Thongtang N; Wolf PA; Schaefer EJ
    Arch Neurol; 2012 May; 69(5):594-600. PubMed ID: 22213409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High insulinlike growth factor binding protein 1 level predicts incident congestive heart failure in the elderly.
    Kaplan RC; McGinn AP; Pollak MN; Kuller L; Strickler HD; Rohan TE; Cappola AR; Xue X; Psaty BM
    Am Heart J; 2008 Jun; 155(6):1006-12. PubMed ID: 18513511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Novel Causal Blood Biomarkers Linking Metabolically Favorable Adiposity With Type 2 Diabetes Risk.
    Pigeyre M; Sjaarda J; Mao S; Chong M; Hess S; Yusuf S; Gerstein H; Paré G
    Diabetes Care; 2019 Sep; 42(9):1800-1808. PubMed ID: 31235487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke.
    Kaplan RC; McGinn AP; Pollak MN; Kuller LH; Strickler HD; Rohan TE; Cappola AR; Xue X; Psaty BM
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1319-25. PubMed ID: 17264182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The insulin-like growth factor family and breast cancer prognosis: A prospective cohort study among postmenopausal women in Denmark.
    Kalledsøe L; Dragsted LO; Hansen L; Kyrø C; Grønbæk H; Tjønneland A; Olsen A
    Growth Horm IGF Res; 2019 Feb; 44():33-42. PubMed ID: 30622040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults.
    Kaplan RC; McGinn AP; Pollak MN; Kuller L; Strickler HD; Rohan TE; Xue X; Kritchevsky SB; Newman AB; Psaty BM
    J Am Geriatr Soc; 2008 Apr; 56(4):652-60. PubMed ID: 18312313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like Growth Factor-1 and IGF Binding Proteins Predict All-Cause Mortality and Morbidity in Older Adults.
    Zhang WB; Aleksic S; Gao T; Weiss EF; Demetriou E; Verghese J; Holtzer R; Barzilai N; Milman S
    Cells; 2020 Jun; 9(6):. PubMed ID: 32492897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study.
    Chouraki V; Beiser A; Younkin L; Preis SR; Weinstein G; Hansson O; Skoog I; Lambert JC; Au R; Launer L; Wolf PA; Younkin S; Seshadri S
    Alzheimers Dement; 2015 Mar; 11(3):249-57.e1. PubMed ID: 25217292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers of microvascular endothelial dysfunction predict incident dementia: a population-based prospective study.
    Holm H; Nägga K; Nilsson ED; Ricci F; Melander O; Hansson O; Bachus E; Magnusson M; Fedorowski A
    J Intern Med; 2017 Jul; 282(1):94-101. PubMed ID: 28407377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.